Gilenya®

Active substance

Fingolimod

Holder

Novartis Pharma NV

Status

closed

Indication

treatment of patients with relapsing-remitting multiple sclerosis (RRMS) who are included in medical need program CFTY720DBE02_C_IPS .

Public documents 

Approbation

Information for the patient

Informed consent

Last update

13/12/2022